Curtis Lockshin
2020
In 2020, Curtis Lockshin earned a total compensation of $347.2K as Chief Scientific Officer at Xenetic Biosciences, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $38,900 |
|---|---|
| Salary | $285,000 |
| Other | $23,303 |
| Total | $347,203 |
Lockshin received $285K in salary, accounting for 82% of the total pay in 2020.
Lockshin also received $38.9K in non-equity incentive plan and $23.3K in other compensation.
Rankings
In 2020, Curtis Lockshin's compensation ranked 11,867th out of 13,090 executives tracked by ExecPay. In other words, Lockshin earned more than 9.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,867 out of 13,090 | 9th |
Division Manufacturing | 5,070 out of 5,617 | 10th |
Major group Chemicals And Allied Products | 2,067 out of 2,248 | 8th |
Industry group Drugs | 1,803 out of 1,948 | 7th |
Industry Pharmaceutical Preparations | 1,339 out of 1,453 | 8th |
Source: SEC filing on October 17, 2022.
Lockshin's colleagues
We found two more compensation records of executives who worked with Curtis Lockshin at Xenetic Biosciences in 2020.